Acute Myeloid Leukemia With t(8;21); (q22; q22.1); RUNX1-RUNX1T1 Clinical Trials in Houston, Texas

Fludarabine Phosphate, Cytarabine, Filgrastim-sndz, Gemtuzumab Ozogamicin, and Idarubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome